about
ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28The CD300a (IRp60) inhibitory receptor is rapidly up-regulated on human neutrophils in response to inflammatory stimuli and modulates CD32a (FcgammaRIIa) mediated signalingStudy of the interaction of the medium chain mu 2 subunit of the clathrin-associated adapter protein complex 2 with cytotoxic T-lymphocyte antigen 4 and CD28Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activationAdvances in immunotherapy for treatment of lung cancerAnticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12Homeostasis and function of regulatory T cells (Tregs) in vivo: lessons from TCR-transgenic TregsCTLA-4 blockade in tumor models: an overview of preclinical and translational researchImmunotherapy in the treatment of non-small cell lung cancerIpilimumab: an anti-CTLA-4 antibody for metastatic melanomaThe optimal partnership of radiation and immunotherapy: from preclinical studies to clinical translationICOS co-stimulatory receptor is essential for T-cell activation and functionCytotoxic T lymphocyte antigen 4 gene polymorphism confers susceptibility to type 1 diabetes in Japanese children: analysis of association with HLA genotypes and autoantibodiesCEACAM1: contact-dependent control of immunityInteractions of HLA-DRB4 and CTLA-4 genes influence thyroid function in Hashimoto's thyroiditis in Japanese populationCTLA-4 trafficking and surface expressionSrc-like adaptor protein (SLAP) is a negative regulator of T cell receptor signalingCD80 cytoplasmic domain controls localization of CD28, CTLA-4, and protein kinase Ctheta in the immunological synapseProtein disulfide isomerases are antibody targets during immune-mediated tumor destruction.CTLA-4 activation of phosphatidylinositol 3-kinase (PI 3-K) and protein kinase B (PKB/AKT) sustains T-cell anergy without cell death.The role of CTLA-4 in the regulation of T cell immune responses.Tumor necrosis factor-alpha and the progression of diabetes in non-obese diabetic mice.Different modes of pathogenesis in T-cell-dependent autoimmunity: clues from two TCR transgenic systems.Stimulatory effect of Echinacea purpurea extract on the trafficking activity of mouse dendritic cells: revealed by genomic and proteomic analyses.Regulated secretion from hemopoietic cells.Anti-hepatocarcinoma activity of TT-1, an analog of melittin, combined with interferon-α via promoting the interaction of NKG2D and MICAWSX1 expression in tumors induces immune tolerance via suppression of effector immune cells.Immune tolerance induction by integrating innate and adaptive immune regulators.Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection.Abscisic acid ameliorates experimental IBD by downregulating cellular adhesion molecule expression and suppressing immune cell infiltration.Role of heat shock proteins in protection from and pathogenesis of infectious diseases.Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trial.Role of TGF-beta in immune-evasion of cancer.Costimulatory pathways in transplantation.Treg lymphocytes in autoimmune uveitis.Immunosuppression without immunosuppression? How to be a tolerant individual in a dangerous world.Effects of different up-dosing regimens for hymenoptera venom immunotherapy on serum CTLA-4 and IL-10.Evaluation of six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trial
P2860
Q22001503-0F2C10ED-CB6D-4FEF-AE34-C0ACBAA9FCC3Q24313247-9A60289F-0854-4F3C-AAB9-2E57CEA6800FQ24533483-F24D00CF-4B15-438B-9243-B4CB6AAAA09AQ24535835-C6E9C542-47BD-4254-A4C8-A83AE45A18D5Q24646989-05B6BC36-C6AB-434B-9A08-8DB3EACEDAA4Q24675931-A18031EA-7F2A-46C5-A18A-FF6178B572ADQ26778790-C2EA8019-1BC6-44E5-BC1F-F1251BCDF12FQ26796316-A1B11C8B-0F8F-4CDF-B5F5-0C32AEAB7F98Q26853599-B6A25A5A-23AC-4AA3-9321-C9B556CFAA63Q26992295-9B8ECDA2-C7A0-4FD0-B5DB-C5997B317EDBQ27000382-4E94759E-7104-43FD-81D9-6FA998C31A00Q27005902-6BB7C63C-0FBB-4FF4-A044-DBBC37BEBC68Q27024106-A024D27F-E692-427C-8035-2A98D2EC5C15Q28187985-253A3CF6-B99A-4179-AB86-94073DF3DEA2Q28207306-A4A9844B-C0FC-4FE6-9B92-7ADF24EA5DCEQ28242244-3BC6BC9D-971F-4C68-B42C-5BD06E56569DQ28253789-BA98A1EF-0587-4F7C-B4E6-E0A357E696A9Q28279561-88F3C315-284E-4068-A936-A86FE5FBAA73Q30175252-7BFD85DF-DE4D-4025-8537-34DD8B45E788Q30478206-5CCAD6CB-9FEE-4015-B487-660905B07D11Q33384384-2F837716-6E27-4C04-8487-351A22A57915Q33389175-EA16E1AE-DD0D-471A-91DE-3237D27907ABQ33547785-E06FB500-64D9-4BF7-A6CC-C52448C97E96Q33713257-FDD87F02-1624-4151-B19A-EB883518E727Q33713313-CE1B3DAC-85EA-4892-9A63-567D4FB9F4CDQ33735322-54742DCE-E99C-4F1F-BC27-FADF35667761Q33745488-8B7B5BA5-AFCF-4A65-B984-DC6533959D98Q33825926-63D621BE-EEC9-45BF-8495-328978CC1731Q33895262-447A010F-FDD6-4D8C-83B8-3C366F83404FQ33907609-D779965A-D826-4929-A232-D3FCC144EEB6Q33930475-C1D2412E-0CAE-4CDC-ABE7-8CAC1AF8CD18Q33952480-697E0FB6-4C97-48E1-A550-581AB8518084Q33975393-72E76151-B01D-4D62-AFF6-E1648DC03C6FQ34058870-FB16F8C9-FC48-4132-895A-55B3FAF2C58CQ34136492-C77D61E5-9127-45F2-A89D-51774241916AQ34187594-22F5ED62-3841-4C1C-8D1C-1D469CD6DDDCQ34273253-8326FDCA-7A0A-414B-AA71-754C6A451C81Q34294802-29CA392A-35EE-446E-A072-0F207B68CF63Q34313790-FE175D28-6DA1-41CF-803D-6FD2F89467A6Q34335379-89F55487-7720-44CF-B029-D8F8013FC51B
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
The emerging role of CTLA-4 as an immune attenuator.
@en
type
label
The emerging role of CTLA-4 as an immune attenuator.
@en
prefLabel
The emerging role of CTLA-4 as an immune attenuator.
@en
P1433
P1476
The emerging role of CTLA-4 as an immune attenuator.
@en
P2093
C B Thompson
J P Allison
P304
P356
10.1016/S1074-7613(00)80366-0
P407
P577
1997-10-01T00:00:00Z